These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23643067)

  • 1. Parenteral vs oral iron in patients with inflammatory bowel disease: quantifying information size by trial sequential analysis.
    Messori A; Fadda V; Maratea D
    J Crohns Colitis; 2013 Nov; 7(10):e495-6. PubMed ID: 23643067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is intravenous iron really useful in inflammatory bowel disease? Would oral iron not be simpler and cheaper?].
    Bermejo San José F
    Gastroenterol Hepatol; 2009 Jan; 32(1):63-4. PubMed ID: 19174104
    [No Abstract]   [Full Text] [Related]  

  • 3. The Efficiency of Intravenous Iron Therapy in Korean Inflammatory Bowel Disease Patients.
    Kim KO
    Gut Liver; 2016 Jul; 10(4):487-8. PubMed ID: 27377734
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous iron in inflammatory bowel disease.
    Auerbach M
    Am J Hematol; 2014 Aug; 89(8):862. PubMed ID: 24890797
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.
    de Silva AD; Tsironi E; Feakins RM; Rampton DS
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1097-105. PubMed ID: 16305723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
    Khalil A; Goodhand JR; Wahed M; Yeung J; Ali FR; Rampton DS
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1029-35. PubMed ID: 21857526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in inflammatory bowel diseases is much more than levels of hemoglobin.
    Bager P
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):145-6. PubMed ID: 26114170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythropoietin and intravenous iron to save blood in surgery].
    Beris P;
    Praxis (Bern 1994); 2004 Nov; 93(46):1905-10. PubMed ID: 15580882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron prophylaxis in pregnancy: intravenous route versus oral route.
    Bencaiova G; von Mandach U; Zimmermann R
    Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):135-9. PubMed ID: 19406557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron in inflammatory bowel diseases.
    Gomollón F; Gisbert JP
    Curr Opin Gastroenterol; 2013 Mar; 29(2):201-7. PubMed ID: 23274316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues of study design and data analysis.
    D'Agostino RB
    Inflamm Bowel Dis; 1998 May; 4(2):109-111; discussion 111-3. PubMed ID: 9687216
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trace elements in parenteral feeding].
    Seeling W; Seeling I; Ahnefeld FW; Dick W; Grünert A
    Klin Anasthesiol Intensivther; 1978; (16):117-41. PubMed ID: 414006
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F; Löhr B; Laubender RP; Tillack C; Schnitzler F; Breiteneicher S; Weidinger M; Göke B; Seiderer J; Ochsenkühn T; Brand S
    Digestion; 2012; 85(1):47-54. PubMed ID: 22179489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron and parenteral nutrition.
    Forbes A
    Gastroenterology; 2009 Nov; 137(5 Suppl):S47-54. PubMed ID: 19874949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What FDA is doing about multivitamins and trace elements for parenteral use.
    Troendle G
    J Parenter Sci Technol; 1981; 35(2):72-3. PubMed ID: 7229837
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.
    D'Haens G; Feagan B; Colombel JF; Sandborn WJ; Reinisch W; Rutgeerts P; Carbonnel F; Mary JY; Danese S; Fedorak RN; Hanauer S; Lémann M;
    Gastroenterology; 2012 Dec; 143(6):1461-9. PubMed ID: 23000597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of trace elements in intravenous hyperalimentation solutions.
    Hull RL
    Am J Hosp Pharm; 1974 Aug; 31(8):759-61. PubMed ID: 4212506
    [No Abstract]   [Full Text] [Related]  

  • 19. Trace elements in parenteral nutrition: a practical guide for dosage and monitoring for adult patients.
    Fessler TA
    Nutr Clin Pract; 2013 Dec; 28(6):722-9. PubMed ID: 24163318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of anaemia in inflammatory bowel disease.
    Koutroubakis IE; Karmiris K; Kouroumalis EA
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1273-4; author reply 1274-5. PubMed ID: 16611290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.